Articles in section Research & Development
| << Opinion & Analysis | 457 articles | Royalties >> |
| << Previous | Pages 1 ..2 3 4 5 6 7 .. 46 | Next >> |
-
Merck & Co. Pays US$35 M Upfront for Kelun-Biotech’s ADC Oncology Drug
-
Merck & Co. Collaborates with Orion to Develop and Commercialise ODM-208 for US$290 M
-
Generian and Mitobridge Form Alliance to Develop Novel Small Molecules for Undruggable Targets
-
Sanofi Signs US$2.54 B Collaboration Deal with Skyhawk Therapeutics for RNA-splicing Modulators
-
Novartis Collaborates with Precision Bio in Gene Editing Pact
-
Amphista Enters Protein Degradation Collaborations with Bristol-Myers Squibb and Merck
-
Takeda Signs US$400 M+ Gene Therapy Pact with Evozyne
-
Bristol Myers Squibb Signs US$1.1 B Metastatic Cancer Pact with Volastra
-
Curve Therapeutics Collaborates with Merck & Co. on Next Generation Drug Discovery Platform
-
Intellia and ONK Collaborate on CRISPR-Edited Cancer Cell Therapies
RSS